Cancer Stem Cells in Multiple Myeloma

Completed

• Conditions: Multiple Myeloma

• Registration Number: NCT01820546
• Lead Sponsor: Ankara University

Brief Summary

In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.

Detailed Description

The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their prognostic value and check for any relationship between cancer stem cell quantification and chemotherapy response are main aims of this study.

Study Timeline

• Study Start: 2013-01
• Study First Submitted: 2013-03-26
• Study First Submitted QC: 2013-03-26
• Study First Posted: 2013-03-28
• Status Verified: 2016-01
• Primary Completion: 2016-01
• Study Completion: 2016-01
• Last Update Submitted: 2016-01-04
• Last Update Posted: 2016-01-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

• New Diagnosed or Relapsed Multiple Myeloma
• Routine Bone Marrow Aspiration will be done

Exclusion Criteria

• Bone Marrow Aspiration is not Needed

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment Response	3 months	After 3 courses chemotherapy treatment response

Secondary Outcome Measures

Name	Time	Method
Treatment Response	6 months	After 6 courses chemotherapy treatment response

Trial Locations

Locations (1)

Ankara University Hematology Unit; 🇹🇷 Ankara, Turkey